Research suggests that certain compounds derived from human vaginal probiotic isolates may have antimicrobial properties, potentially inhibiting the growth of uropathogenic E. coli biofilms. The specific mechanisms and compounds involved are being studied, with some findings indicating that these probiotic isolates can mediate matrix inhibition and thwart biofilm formation. The discovery of these properties may have implications for the development of novel therapeutics for urinary tract infections.